title: Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
abstract: Aiming at more precise detection of melanoma cells in sentinel lymph nodes and better understanding of the mechanisms underlying metastatic spread, expression of L1, CEACAM1, and binding of the lectins HPA, ML-I and PNA, was assessed in benign nevi (n=12), primary melanomas (PTs: n=67), their corresponding sentinel lymph nodes (SLNs: n=40), and distant metastases (DMs: n=35). Sensitivity and specificity of CEACAM1 (95-97%; 66%) and L1 (90-93%; 100%) exceeded that of the standard markers MelanA, S100, and HMB45 in single marker use. Lectin binding was found in PTs and DMs (HPA: 69% and 77%; ML-I: 82% and 77%, respectively), but rarely in SLNMs (HPA: 20%, ML-I: 20%, PNA: 5%, respectively). The highly specific and sensitive L1-11A against L1 and 4D1/C2 against CEACAM1 antibodies are a worthy completion to standard antibody panels for diagnosis of melanoma cells. Both CAMs seem to be functionally involved in lymphatic and haematogenous spread, and are thus promising target molecules for immunotoxins.
authors.affiliation: Institut für Anatomie II: Experimentelle Morphologie, Zentrum für Experimentelle Medizin, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. thies@uke.uni-hamburg.de
authors.forename: Anka
authors.initials: A
authors.lastname: Thies
authors.forename: Anke
authors.initials: A
authors.lastname: Berlin
authors.forename: Georg
authors.initials: G
authors.lastname: Brunner
authors.forename: Hans-Joachim
authors.initials: HJ
authors.lastname: Schulze
authors.forename: Ingrid
authors.initials: I
authors.lastname: Moll
authors.forename: Uwe
authors.initials: U
authors.lastname: Pfüller
authors.forename: Christoph
authors.initials: C
authors.lastname: Wagener
authors.forename: Melitta
authors.initials: M
authors.lastname: Schachner
authors.forename: Peter
authors.initials: P
authors.lastname: Altevogt
authors.forename: Udo
authors.initials: U
authors.lastname: Schumacher
mesh_terms: D015703:Antigens, CD / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D015815:Cell Adhesion Molecules / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis*; D006801:Humans; D007150:Immunohistochemistry; D037102:Lectins / Q000378:metabolism; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis; D008198:Lymph Nodes / Q000737:chemistry / Q000473:pathology*; D008207:Lymphatic Metastasis; D058965:MART-1 Antigen; D008545:Melanoma / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000032:analysis; D011379:Prognosis; D011485:Protein Binding; D009418:S100 Proteins / Q000032:analysis; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology
chemical_list: D015703:Antigens, CD; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; C069847:CD66 antigens; D015815:Cell Adhesion Molecules; D006023:Glycoproteins; D037102:Lectins; D039841:Leukocyte L1 Antigen Complex; D058965:MART-1 Antigen; C548667:MLANA protein, human; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D009418:S100 Proteins